Back to Screener

Healthcare

Prelude Therapeutics Incorporated(PRLD)

Live Price

Offline

$4.32

-0.69% today

1Y Change

+430.95%

Window

Jun 23, 2025 โ†’ Jun 15, 2026

Market Cap
$260.00M
Revenue Growth
+73.4%
EPS Growth
+23.2%
Dividend Yield
0.0%

Coverage: 247 bars ยท Jun 23, 2025 โ†’ Jun 15, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Prelude Therapeutics Incorporated (PRLD) is a Healthcare stock with a market cap of $260.00M and listed on NASDAQ. The stock last traded around $4.32 and up 431.0% across the available one-year price window (Jun 23, 2025 โ†’ Jun 15, 2026). Baseline metrics include revenue growth of +73.4%, EPS growth of +23.2%, a dividend yield of 0.0%. What stands out right now is revenue +73.4%, EPS +23.2%, free cash flow +45.6% with operating margin -861.3% and ROIC -114.8%. Valuation already assumes a fairly strong business story at price/sales 21.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PRLD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

PRLD

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

PRLD Max Drawdown

-70.10%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for PRLD and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 5, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 5, 26
โ€”
Est -0.24
โ€”
โ€”
Est 5882.7B
โ€”
May 5
โ€”
Mar 10, 26
โœ“
-0.20
Est -0.33
+39.4%
5600.0B
Est 20500.0B
-72.7%
Mar 10
โ€”
Nov 12, 25
โœ“
-0.26
Est -0.35
+25.7%
6500.0B
Est 20500.0B
-68.3%
Nov 12
โ€”
Aug 14, 25
โœ“
-0.41
Est -0.45
+8.9%
โ€”
Est โ€”
โ€”
Aug 14
โ€”
May 6, 25
โœ“
-0.42
Est -0.47
+10.6%
โ€”
Est โ€”
โ€”
May 6
โ€”
Mar 10, 25
โœ“
-0.38
Est -0.49
+22.4%
4000.0B
Est โ€”
โ€”
Mar 10
โ€”
Nov 6, 24
โœ“
-0.43
Est -0.48
+10.4%
3000.0B
Est โ€”
โ€”
Nov 6
โ€”
Aug 12, 24
โ€”
-0.46
Est -0.46
0.0%
โ€”
Est โ€”
โ€”
Aug 12
โ€”
May 7, 24
โœ“
-0.42
Est -0.47
+10.6%
โ€”
Est โ€”
โ€”
May 7
โ€”
Feb 15, 24
โœ“
-0.47
Est -0.50
+6.0%
3424.0B
Est โ€”
โ€”
Feb 15
โ€”
Nov 1, 23
โœ“
-0.45
Est -0.58
+22.4%
โ€”
Est โ€”
โ€”
Nov 1
โ€”
Aug 3, 23
โœ“
-0.54
Est -0.65
+16.9%
โ€”
Est โ€”
โ€”
Aug 3
โ€”
May 8, 23
โœ“
-0.58
Est -0.68
+14.7%
โ€”
Est โ€”
โ€”
May 8
โ€”
Mar 15, 23
โœ“
-0.60
Est -0.63
+4.8%
โ€”
Est โ€”
โ€”
Mar 15
โ€”
Nov 14, 22
โ€”
-0.63
Est -0.63
0.0%
โ€”
Est โ€”
โ€”
Nov 14
โ€”
Aug 9, 22
โœ“
-0.58
Est -0.60
+3.3%
โ€”
Est โ€”
โ€”
Aug 9
โ€”
May 10, 22
โœ“
-0.63
Est -0.68
+7.3%
โ€”
Est โ€”
โ€”
May 10
โ€”
Mar 16, 22
โœ—
-0.71
Est -0.69
-2.9%
โ€”
Est โ€”
โ€”
Mar 16
โ€”
Nov 12, 21
โœ—
-0.66
Est -0.62
-6.5%
โ€”
Est โ€”
โ€”
Nov 12
โ€”
Aug 12, 21
โœ—
-0.58
Est -0.51
-13.7%
โ€”
Est โ€”
โ€”
Aug 12
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener